{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:40:52Z","timestamp":1760179252808,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12288-024-01946-0","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:16:48Z","timestamp":1735276608000},"page":"782-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of the Therapeutic Efficacy of Decitabine Combined with Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor (D-CAG) Versus CAG Regimen in the Treatment of Acute Myeloid Leukemia"],"prefix":"10.1007","volume":"41","author":[{"given":"Maowen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghuizi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoru","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"1946_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12032-023-02056-z","volume":"40","author":"H Wang","year":"2023","unstructured":"Wang H, Zhou J, Ma X, Jiao C, Chen E, Wu Z et al (2023) Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells. Med Oncol 40:193","journal-title":"Med Oncol"},{"key":"1946_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00277-023-05119-3","volume":"102","author":"M Cerrano","year":"2023","unstructured":"Cerrano M, Chevret S, Raffoux E, Rabian F, S\u00e9bert M, Valade S et al (2023) Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. Ann Hematol 102:761\u2013768","journal-title":"Ann Hematol"},{"key":"1946_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3324\/haematol.2022.281221","volume":"108","author":"G Stalder","year":"2023","unstructured":"Stalder G, Suffiotti M, Segot A, Noto A, Pantaleo G, Spertini O et al (2023) Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial. Haematologica 108:234\u2013239","journal-title":"Haematologica"},{"key":"1946_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1080\/03007995.2020.1808452","volume":"36","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Bin T, Chen JOU, Chen S (2020) Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report. Curr Med Res Opin 36:1807\u20131812","journal-title":"Curr Med Res Opin"},{"key":"1946_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/jpm11030193","volume":"11","author":"DJ Wooten","year":"2021","unstructured":"Wooten DJ, Gebru M, Wang HG, Albert R (2021) Data-driven math model of FLT3-ITD acute myeloid leukemia reveals potential therapeutic targets. J Pers Med 11:193","journal-title":"J Pers Med"},{"key":"1946_CR6","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1007\/s00277-020-04285-y","volume":"100","author":"DC Moore","year":"2021","unstructured":"Moore DC, Nelson V, Muslimani A (2021) Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma. Ann Hematol 100:3053\u20133055","journal-title":"Ann Hematol"},{"key":"1946_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ajh.25903","volume":"96","author":"A Hastings","year":"2021","unstructured":"Hastings A, Apperley JF, Nadal-Melsio E, Brown L, Bain BJ (2021) Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13). Am J Hematol 96:163\u2013164","journal-title":"Am J Hematol"},{"key":"1946_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/diseases10030054","volume":"10","author":"HF Bahmad","year":"2022","unstructured":"Bahmad HF, Gogola S, Elajami MK, Brathwaite C, Castellano-S\u00e1nchez AA, Sriganeshan V et al (2022) Hemophagocytic lymphohistiocytosis in the setting of therapy-induced acute myeloid leukemia: an autopsy report. Diseases 10:54","journal-title":"Diseases"},{"key":"1946_CR9","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/cncr.33539","volume":"127","author":"K Morita","year":"2021","unstructured":"Morita K, Kantarjian HM, Sasaki K, Issa GC, Jain N, Konopleva M et al (2021) Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib. Cancer 127:2641\u20132647","journal-title":"Cancer"},{"key":"1946_CR10","unstructured":"\u0160ulav\u00edkov\u00e1 Z, Anwarzai J, Kr\u00e1snik V (2022) Acute retinal necrosis after intravitreal dexamethasone implant. a case report. Cesk Slov Oftalmol 78:144\u2013148"},{"key":"1946_CR11","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1182\/blood.2019003124","volume":"136","author":"MT Gebru","year":"2020","unstructured":"Gebru MT, Atkinson JM, Young MM, Zhang L, Tang Z, Liu Z et al (2020) Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia. Blood 136:1067\u20131079","journal-title":"Blood"},{"key":"1946_CR12","doi-asserted-by":"publisher","first-page":"e29452","DOI":"10.1002\/pbc.29452","volume":"69","author":"PS Hinds","year":"2022","unstructured":"Hinds PS, Pinheiro LC, McFatrich M, Waldron M, Baker JN, Mowbray C et al (2022) Recommended scoring approach for the pediatric patient-reported outcomes version of the common terminology criteria for adverse events. Pediatr Blood Cancer 69:e29452","journal-title":"Pediatr Blood Cancer"},{"key":"1946_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/ejh.13183","volume":"102","author":"S Bertoli","year":"2019","unstructured":"Bertoli S, Paubelle E, B\u00e9rard E, Saland E, Thomas X, Tavitian S et al (2019) Ferritin heavy\/light chain (FTH1\/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. Eur J Haematol 102:131\u2013142","journal-title":"Eur J Haematol"},{"key":"1946_CR14","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.12998\/wjcc.v11.i21.5129","volume":"11","author":"SY Jeon","year":"2023","unstructured":"Jeon SY, Lee NR, Cha S, Yhim HY, Kwak JY, Jang KY et al (2023) Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine: A case report. World J Clin Cases 11:5129\u20135135","journal-title":"World J Clin Cases"},{"key":"1946_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/bjh.17940","volume":"196","author":"HMM Ahmed","year":"2022","unstructured":"Ahmed HMM, Nimmagadda SC, Al-Matary YS, Fiori M, May T, Frank D et al (2022) Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells. Br J Haematol 196:995\u20131006","journal-title":"Br J Haematol"},{"key":"1946_CR16","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.2147\/OTT.S312494","volume":"14","author":"J Mao","year":"2021","unstructured":"Mao J, Xue L, Wang H, Zhu Y, Wang J, Zhao L (2021) A new treatment strategy for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review. Onco Targets Ther 14:3795\u20133802","journal-title":"Onco Targets Ther"},{"key":"1946_CR17","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/15257770.2020.1780441","volume":"39","author":"AC Jaramillo","year":"2020","unstructured":"Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J et al (2020) Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase. Nucleosides Nucleotides Nucleic Acids 39:1346","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"1946_CR18","doi-asserted-by":"publisher","first-page":"1001482","DOI":"10.3389\/fimmu.2022.1001482","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Tang J, Feng J, Huang Y, Cheng Y, Xu H et al (2022) Case report: a rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations. Front Immunol 13:1001482","journal-title":"Front Immunol"},{"key":"1946_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1177\/10781552221076756","volume":"28","author":"U Atas","year":"2022","unstructured":"Atas U, Aydin Ersoy M, Iltar U, Yucel OK, Turkoglu EB, Salim O (2022) Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia. J Oncol Pharm Pract 28:1474\u20131477","journal-title":"J Oncol Pharm Pract"},{"key":"1946_CR20","first-page":"625","volume":"40","author":"AJ Huang","year":"2019","unstructured":"Huang AJ, Wang LB, Du J, Tang GS, Cheng H, Gong SL et al (2019) Efficacy of Hyper-CVAD\/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old. Zhonghua Xue Ye Xue Za Zhi 40:625\u2013632","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1946_CR21","doi-asserted-by":"publisher","first-page":"e28285","DOI":"10.1002\/pbc.28285","volume":"67","author":"R Yanagisawa","year":"2020","unstructured":"Yanagisawa R, Kato M, Sakaguchi K, Nakagoshi R, Ogiso Y, Fukushima K et al (2020) A case of pure erythroid leukemia with MYB-GATA1 fusion that developed tumor lysis syndrome with dexamethasone. Pediatr Blood Cancer 67:e28285","journal-title":"Pediatr Blood Cancer"},{"key":"1946_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.14740\/jmc3758","volume":"12","author":"JL Ramirez Melo","year":"2021","unstructured":"Ramirez Melo JL, Cruz Osorio RM, Santoyo Cueva J, Sanchez Zubieta F, Chavez PA, Fernandez Mendoza LT et al (2021) Sweet syndrome in an adolescent patient with differentiation syndrome secondary to promyelocytic leukemia treatment with all-trans retinoic acid. J Med Cases 12:469\u2013473","journal-title":"J Med Cases"},{"key":"1946_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00277-023-05495-w","volume":"103","author":"D Fischer","year":"2024","unstructured":"Fischer D, Toenges R, Kiil K, Michalik S, Thalhammer A, Bug G et al (2024) Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia. Ann Hematol 103:489\u2013498","journal-title":"Ann Hematol"},{"key":"1946_CR24","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s10637-018-0694-6","volume":"37","author":"MF Maioral","year":"2019","unstructured":"Maioral MF, Stefanes NM, Bigolin \u00c1, Zatelli GA, Philippus AC, de Barcellos Falkenberg M et al (2019) MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells. Invest New Drugs 37:912\u2013922","journal-title":"Invest New Drugs"},{"key":"1946_CR25","first-page":"3123","volume":"42","author":"X Liu","year":"2020","unstructured":"Liu X, Liu YF, Zi JJ, Shu Y, Kong LZ, Zheng Q et al (2020) Effects of HAG combined with decitabine on the expression of inflammatory factors, HIF-1\u03b1 and VEGF in patients with myelodysplastic syndrome. Hebei Med J 42:3123\u20133126","journal-title":"Hebei Med J"},{"key":"1946_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3960\/jslrt.23054","volume":"64","author":"SI Nakagawa","year":"2024","unstructured":"Nakagawa SI, Nukii Y, Mochizuki K, Uchiyama A, Maeda Y, Kurokawa T (2024) A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed. J Clin Exp Hematop 64:59\u201364","journal-title":"J Clin Exp Hematop"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-024-01946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-024-01946-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-024-01946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:07:42Z","timestamp":1760177262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-024-01946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1007\/s12288-024-01946-0","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"type":"print","value":"0971-4502"},{"type":"electronic","value":"0974-0449"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}